middle.news
Acrux CEO Michael Kotsanis to Retire After Driving Decade of Growth
9:36am on Friday 7th of February, 2025 AEDT
•
Pharmaceuticals
Read Story
Acrux CEO Michael Kotsanis to Retire After Driving Decade of Growth
9:36am on Friday 7th of February, 2025 AEDT
Key Points
Michael Kotsanis retiring after over a decade as Acrux CEO
CEO transition planned with orderly handover to successor
Kotsanis credited with developing successful generic drug strategy
Company progressing multiple FDA filings to expand product portfolio
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Acrux (ASX:ACR)
OPEN ARTICLE